Related Experiment Video
Updated: Oct 1, 2026

Optimization of Antigen Preparation for Hemagglutination Inhibition Assay of Newcastle Disease Virus Serology
Published on: January 24, 2025
Acute haemolytic transfusion reactions due to weak antibodies that in vitro did not seem to be clinically significant
B Hoppe1, L Pastucha, A Seltsam
1Institute of Transfusion Medicine, Charité Campus Virchow-Klinikum, Humboldt-Universität Berlin, Germany.
Background And Objectives:
In the present article, we report on two patients with acute haemolytic transfusion reactions (AHTRs), and whom we were unable to transfuse, owing to alloantibodies that in vitro did not seem to be clinically significant.
Materials And Methods:
The patients were a 67-year-old male and a 64-year-old female, both of whom developed antibodies to red blood cells (RBCs) after repeat blood transfusions. Serological analyses were carried out using standard techniques.
Results:
Both patients developed an AHTR of the intravascular type following blood transfusions. Serological re-examination revealed weakly reactive alloantibodies with anti-JMH specificity in one patient, and with unclear specificity in the second. Rechallenging the patients with 15-30 ml of packed RBCs caused AHTRs, and blood transfusion became impossible in both cases.
Conclusion:
Weak alloantibodies that in vitro do not seem to be clinically significant may cause severe AHTRs.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Hypersensitivity Reactions: Cytolytic Reactions
Drug toxicity: Idiosyncratic Reactions
Hemodialysis II: Procedure and Complications
Anticoagulant Drugs: Low-Molecular-Weight Heparins
